The global plantibodies market is expected to show a robust growth with an impressive CAGR in the forecast years 2022-2026, on the account of increased involvement of plants for the medicinal purposes. Advancing therapeutics and biotechnological procedures to develop medicines and drugs by utilizing plant-antibody conjugation is further driving the growth of the global plantibodies market in the upcoming five years.

Plantibodies are the plant-antibodies that have the ability to counter a specific pathogen action. These antibodies are produced by plants after genetic manipulation of the plant DNA with the animal DNA codes. The specific target pathogen is countered with the plantibody thus neutralizes the action of the pathogen or the toxin in the animal cell. Genetically engineered plants known as transgenic plants are utilized, to produce plantibodies that has similar action as the human antibody. Utilizing the transgenic plants for the multiplication and production of the plantibodies to increase the yield of the antibodies such that drug development can be done, offers advanced and beneficial procedure of drug development.

Pharmaceutical Industry Expansion Drives Market Growth

Surge in the demand for the effective drugs for the increasing number of pathogen infected diseases is driving the growth of the global plantibodies market indirectly in the upcoming five years. Pharmaceutical sector is ever expanding and with increased researches and innovative product development is further expected to support the growth of the global plantibodies market in the next five years. Although plantibody is a trademark of Biolex Therapeutics Inc., after its dissolution in 2012, the term generalized for plant-antibody conjugation.

Market leaders like Mapp Pharmaceuticals, developed the first ever pharmaceutical product like experimental Ebola drug, and then further drug development through plantibodies escalated in the subsequent years. Multiple pharmaceutical companies are currently actively involved in the production of antibodies, protein drugs and vaccines in fast-growing transgenic plants. Creating plantibodies is more cost effective as compared to conventional antibody manufacturing processes and thus aids the financial investment by the pharmaceutical market players in their drug development processes.

Biotechnological Advancement Supports Market Growth

Advancing biotechnological sector is one of the major driving factors for the global plantibodies market. Techniques like genetic manipulation, genetic engineering in plants, genetically modified plant breeding and sexual crossings support the growth of the global plantibodies market in the upcoming five years. Since 1990s the plants are utilized as bioreactors to produce efficient vaccinations against viral, bacterial and other pathogenic infectious diseases.

Government bodies and pharmaceutical companies invest heavily in the research centers to support their academic and product development studies such that drug & therapeutic development against various pathogens can be developed. For example, Tobacco (Nicotiana benthamiana) is utilized that creates an antigenic epitope Hemagglutinin (HA), by the method of agrobacterium-mediated transformation to counter the effect of influenza virus and thus helps in drug development caused by the virus.

Expanding Application Arenas Substantiate Future Market Growth

Plantibodies have multiple application including pharmaceutical and therapeutical applications. Other application includes immunization, immunomodulation, along with bioreactor applications. Development of vaccine creates the much needed resistance in an individual against the specific antigen/ pathogen. Also, protein development through the genetically modified plant forms pharmaceutical polypeptides. The list of other plant proteins that are produced through transgenic plants include cytokines, hormones, enzymes, epidermal growth factors, interferons, human protein C, etc.


Click here to download the sample

Market Segmentation

The global plantibodies market is segmented on the basis of transgenic crop, technique, application, end user, competitional landscape, and regional distribution. Based on transgenic crop, the market is further fragmented into tobacco, legumes, cereals, seeds & tubers, fruits & vegetables, and others. On the basis of technique, the market is bifurcated into conventional method, tissue culture, breeding & sexual crossing, transgenic seeds, and others. Application segmentation of the market includes autoimmune diseases, cancer, infectious diseases, immunization, dentistry, and others.

Based on end user, the market is again sub-segmented into biotechnology & pharmaceutical companies, academic & research institutes, and others. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among Asia-Pacific region, North American region, European region, South American region, and Middle East & African region.

Company Profiles

PlantForm Corporation, Planet Biotechnology Inc., iBio, Inc., Mapp Biopharmaceutical, Inc. (Allergan, Inc.), Medicago Inc., NOMAD Bioscience GmbH, Ventria Bioscience Inc., are among the major market players in the global platform that lead the market growth of the global plantibodies market.

Attribute

Details

Base Year

2020

Historical Data

2016 – 2019

Estimated Year

2021

Forecast Period

2022 – 2026

Quantitative Units

Revenue in USD Million, and CAGR for 2016-2020 and 2021-2026

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

  • Transgenic Crop
  • Technique
  • Application
  • End User

Regional scope

North America; Europe; Asia Pacific; South America; Middle East & Africa

Country scope

United States, Mexico, Canada, China, India, Japan, South Korea, Australia, Thailand, Singapore, Germany, France, United Kingdom, Spain, Italy, South Africa, UAE, Saudi Arabia, Brazil, Argentina, Colombia

Key companies profiled

PlantForm Corporation, Planet Biotechnology Inc., iBio, Inc., Mapp Biopharmaceutical, Inc. (Allergan, Inc.), Medicago Inc., NOMAD Bioscience GmbH, Ventria Bioscience Inc.,

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, global plantibodies market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Plantibodies Market, By Transgenic Crop:
    • Tobacco
    • Legumes
    • Cereals
    • Seeds & Tubers
    • Fruits & Vegetables
    • Others
  • Plantibodies Market, By Technique:
    • Conventional Method
    • Tissue Culture
    • Breeding & Sexual Crossing
    • Transgenic Seeds
    • Others
  • Plantibodies Market, By Application:
    • Autoimmune Diseases
    • Cancer
    • Infectious Diseases
    • Immunization
    • Dentistry
    • Others
  • Plantibodies Market, By End User:
    • Biotechnology & Pharmaceutical Companies
    • Academic & Research Institutes
    • Others
  • Plantibodies Market, By Region:
    • North America
      • United States
      • Mexico
      • Canada
    • Europe
      • France
      • Germany
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • India
      • Japan
      • South Korea
      • Australia
      • Thailand
      • Singapore
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global plantibodies market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Global Plantibodies Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Plantibodies Market

4.    Executive Summary

5.    Voice of Customer

5.1.  Transgenic Plants/Crops Used for Plantibody Production

5.2.  Criterion for Selecting Host Plant for Plantibody Production

5.3.  Preferred Technique for Plantibodies Production

5.4.  Techniques Used for Purification of Plantibody

5.5.  Techniques Used for Evaluation of Plantibody

5.6.  Barriers to Adoption of Plantibodies

5.7.  Brand Awareness

6.    Clinical Trials

6.1.  Ongoing Clinical Trials

6.2.  Completed Clinical Trials

6.3.  Terminated Clinical Trials

6.4.  Clinical Trial Analysis

7.    Patent Analysis

7.1.  Patent Granted (2016-2020)

7.2.  Patent Applications Filed

8.    List of Commercialized Plantibodies

9.    Global Plantibodies Market Outlook

9.1.  Market Size & Forecast

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Transgenic Crop (Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables, Others)

9.2.2.     By Technique (Conventional Method, Tissue Culture, Breeding & Sexual Crossing, Transgenic Seeds, Others)

9.2.3.     By Application (Autoimmune Diseases, Cancer, Infectious Diseases, Immunization, Dentistry, Others)

9.2.4.     By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutes, Others)

9.2.5.     By Company (2020)

9.2.6.     By Region

9.3.  Product Market Map

10.  North America Plantibodies Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Transgenic Crop

10.2.2.  By Technique

10.2.3.  By Application

10.2.4.  By End User

10.2.5.  By Country

10.3.              North America: Country Analysis

10.3.1.  United States Plantibodies Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Transgenic Crop

10.3.1.2.2.           By Technique

10.3.1.2.3.           By Application

10.3.1.2.4.           By End User

10.3.2.  Mexico Plantibodies Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Transgenic Crop

10.3.2.2.2.           By Technique

10.3.2.2.3.           By Application

10.3.2.2.4.           By End User

10.3.3.  Canada Plantibodies Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Transgenic Crop

10.3.3.2.2.           By Technique

10.3.3.2.3.           By Application

10.3.3.2.4.           By End User

11.  Europe Plantibodies Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Transgenic Crop

11.2.2.  By Technique

11.2.3.  By Application

11.2.4.  By End User

11.2.5.  By Country

11.3.              Europe: Country Analysis

11.3.1.  France Plantibodies Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Transgenic Crop

11.3.1.2.2.           By Technique

11.3.1.2.3.           By Application

11.3.1.2.4.           By End User

11.3.2.  Germany Plantibodies Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Transgenic Crop

11.3.2.2.2.           By Technique

11.3.2.2.3.           By Application

11.3.2.2.4.           By End User

11.3.3.  United Kingdom Plantibodies Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Transgenic Crop

11.3.3.2.2.           By Technique

11.3.3.2.3.           By Application

11.3.3.2.4.           By End User

11.3.4.  Italy Plantibodies Market Outlook

11.3.4.1.      Market Size & Forecast

11.3.4.1.1.           By Value

11.3.4.2.      Market Share & Forecast

11.3.4.2.1.           By Transgenic Crop

11.3.4.2.2.           By Technique

11.3.4.2.3.           By Application

11.3.4.2.4.           By End User

11.3.5.  Spain Plantibodies Market Outlook

11.3.5.1.      Market Size & Forecast

11.3.5.1.1.           By Value

11.3.5.2.      Market Share & Forecast

11.3.5.2.1.           By Transgenic Crop

11.3.5.2.2.           By Technique

11.3.5.2.3.           By Application

11.3.5.2.4.           By End User

12.  Asia-Pacific Plantibodies Market Outlook

12.1.              Market Size & Forecast

12.1.1.  By Value

12.2.              Market Share & Forecast

12.2.1.  By Transgenic Crop

12.2.2.  By Technique

12.2.3.  By Application

12.2.4.  By End User

12.2.5.  By Country

12.3.              Asia-Pacific: Country Analysis

12.3.1.  China Plantibodies Market Outlook

12.3.1.1.      Market Size & Forecast

12.3.1.1.1.           By Value

12.3.1.2.      Market Share & Forecast

12.3.1.2.1.           By Transgenic Crop

12.3.1.2.2.           By Technique

12.3.1.2.3.           By Application

12.3.1.2.4.           By End User

12.3.2.  India Plantibodies Market Outlook

12.3.2.1.      Market Size & Forecast

12.3.2.1.1.           By Value

12.3.2.2.      Market Share & Forecast

12.3.2.2.1.           By Transgenic Crop

12.3.2.2.2.           By Technique

12.3.2.2.3.           By Application

12.3.2.2.4.           By End User

12.3.3.  South Korea Plantibodies Market Outlook

12.3.3.1.      Market Size & Forecast

12.3.3.1.1.           By Value

12.3.3.2.      Market Share & Forecast

12.3.3.2.1.           By Transgenic Crop

12.3.3.2.2.           By Technique

12.3.3.2.3.           By Application

12.3.3.2.4.           By End User

12.3.4.  Japan Plantibodies Market Outlook

12.3.4.1.      Market Size & Forecast

12.3.4.1.1.           By Value

12.3.4.2.      Market Share & Forecast

12.3.4.2.1.           By Transgenic Crop

12.3.4.2.2.           By Technique

12.3.4.2.3.           By Application

12.3.4.2.4.           By End User

12.3.5.  Australia Plantibodies Market Outlook

12.3.5.1.      Market Size & Forecast

12.3.5.1.1.           By Value

12.3.5.2.      Market Share & Forecast

12.3.5.2.1.           By Transgenic Crop

12.3.5.2.2.           By Technique

12.3.5.2.3.           By Application

12.3.5.2.4.           By End User

12.3.6.  Thailand Plantibodies Market Outlook

12.3.6.1.      Market Size & Forecast

12.3.6.1.1.           By Value

12.3.6.2.      Market Share & Forecast

12.3.6.2.1.           By Transgenic Crop

12.3.6.2.2.           By Technique

12.3.6.2.3.           By Application

12.3.6.2.4.           By End User

12.3.7.  Singapore Plantibodies Market Outlook

12.3.7.1.      Market Size & Forecast

12.3.7.1.1.           By Value

12.3.7.2.      Market Share & Forecast

12.3.7.2.1.           By Transgenic Crop

12.3.7.2.2.           By Technique

12.3.7.2.3.           By Application

12.3.7.2.4.           By End User

13.  South America Plantibodies Market Outlook

13.1.              Market Size & Forecast

13.1.1.  By Value

13.2.              Market Share & Forecast

13.2.1.  By Transgenic Crop

13.2.2.  By Technique

13.2.3.  By Application

13.2.4.  By End User

13.2.5.  By Country

13.3.              South America: Country Analysis

13.3.1.  Brazil Plantibodies Market Outlook

13.3.1.1.      Market Size & Forecast

13.3.1.1.1.           By Value

13.3.1.2.      Market Share & Forecast

13.3.1.2.1.           By Transgenic Crop

13.3.1.2.2.           By Technique

13.3.1.2.3.           By Application

13.3.1.2.4.           By End User

13.3.2.  Argentina Plantibodies Market Outlook

13.3.2.1.      Market Size & Forecast

13.3.2.1.1.           By Value

13.3.2.2.      Market Share & Forecast

13.3.2.2.1.           By Transgenic Crop

13.3.2.2.2.           By Technique

13.3.2.2.3.           By Application

13.3.2.2.4.           By End User

13.3.3.  Colombia Plantibodies Market Outlook

13.3.3.1.      Market Size & Forecast

13.3.3.1.1.           By Value

13.3.3.2.      Market Share & Forecast

13.3.3.2.1.           By Transgenic Crop

13.3.3.2.2.           By Technique

13.3.3.2.3.           By Application

13.3.3.2.4.           By End User

14.  Middle East and Africa Plantibodies Market Outlook

14.1.              Market Size & Forecast

14.1.1.  By Value

14.2.              Market Share & Forecast

14.2.1.  By Transgenic Crop

14.2.2.  By Technique

14.2.3.  By Application

14.2.4.  By End User

14.2.5.  By Country

14.3.              MEA: Country Analysis

14.3.1.  South Africa Plantibodies Market Outlook

14.3.1.1.      Market Size & Forecast

14.3.1.1.1.           By Value

14.3.1.2.      Market Share & Forecast

14.3.1.2.1.           By Transgenic Crop

14.3.1.2.2.           By Technique

14.3.1.2.3.           By Application

14.3.1.2.4.           By End User

14.3.2.  Saudi Arabia Plantibodies Market Outlook

14.3.2.1.      Market Size & Forecast

14.3.2.1.1.           By Value

14.3.2.2.      Market Share & Forecast

14.3.2.2.1.           By Transgenic Crop

14.3.2.2.2.           By Technique

14.3.2.2.3.           By Application

14.3.2.2.4.           By End User

14.3.3.  UAE Plantibodies Market Outlook

14.3.3.1.      Market Size & Forecast

14.3.3.1.1.           By Value

14.3.3.2.      Market Share & Forecast

14.3.3.2.1.           By Transgenic Crop

14.3.3.2.2.           By Technique

14.3.3.2.3.           By Application

14.3.3.2.4.           By End User

15.  Market Dynamics

15.1.              Drivers

15.2.              Challenges

16.  Market Trends & Developments

17.  Competitive Landscape

17.1.              PlantForm Corporation

17.2.              Planet Biotechnology Inc

17.3.              iBio, Inc.

17.4.              Mapp Biopharmaceutical, Inc. (Allergan, Inc.)

17.5.              Medicago Inc.

17.6.              NOMAD Bioscience GmbH

17.7.              Ventria Bioscience Inc.

18.  Strategic Recommendations

19.  About Us & Disclaimer

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com